Question · asked by 1 review

Favipiravir vs no treatment, supportive treatment, or other antiviral treatment: Time to clinical improvement (defined as time to a 2‐point reduction in patients’ admission status on WHO’s ordinal scale)

It is very uncertain whether favipiravir changes time to clinical improvement (defined as time to a 2‐point reduction… compared with no treatment, supportive treatment, or other antiviral treatment (very low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Favipiravir vs no treatment, supportive treatment, or other antiviral treatment
Time to clinical improvement (defined as time to a 2‐point reduction in patients’ admission status on WHO’s ordinal scale) · people with confirmed COVID‐19
It is very uncertain whether favipiravir changes time to clinical improvement (defined as time to a 2‐point reduction… compared with no treatment, supportive treatment, or other antiviral treatment (very low certainty).
Favipiravir for treating COVID‐19 (2024) · Cochrane Headline outcomes only
HR 1.13 [0.69, 1.83]4 studies · 721 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Favipiravir for treating COVID‐19
2024 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.